[HTML][HTML] Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
PET imaging using radiolabeled amino acids in addition to MRI has become a valuable
diagnostic tool in the clinical management of patients with brain tumors. This review …
diagnostic tool in the clinical management of patients with brain tumors. This review …
Amino Acid Tracer PET MRI in Glioma Management: What a Neuroradiologist Needs to Know
N Soni, M Ora, A Jena, P Rana… - American Journal …, 2023 - Am Soc Neuroradiology
PET with amino acid tracers provides additional insight beyond MR imaging into the biology
of gliomas that can be used for initial diagnosis, delineation of tumor margins, planning of …
of gliomas that can be used for initial diagnosis, delineation of tumor margins, planning of …
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
Background PET with radiolabeled amino acids is used in the preoperative evaluation of
patients with glial neoplasms. This study aimed to assess the role of [11C] methionine (MET) …
patients with glial neoplasms. This study aimed to assess the role of [11C] methionine (MET) …
Metabolic kinetic modeling of [11C]methionine based on total-body PET in multiple myeloma
J Li, B Ni, X Yu, C Wang, L Li, Y Zhou, Y Gu… - European Journal of …, 2023 - Springer
Purpose Multiple myeloma (MM) is a malignant disease characterized by the secretion of
monoclonal immunoglobulins and has a high demand for amino acids.[11C] methionine …
monoclonal immunoglobulins and has a high demand for amino acids.[11C] methionine …
[HTML][HTML] EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy
Epilepsy is one of the most frequent neurological conditions with an estimated prevalence of
more than 50 million people worldwide and an annual incidence of two million. Although …
more than 50 million people worldwide and an annual incidence of two million. Although …
Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using 18F …
J Lohmeier, H Radbruch, W Brenner… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Molecular markers are of increasing importance for classifying, treating, and determining the
prognosis for central nervous system tumors. Isocitrate dehydrogenase (IDH) is a critical …
prognosis for central nervous system tumors. Isocitrate dehydrogenase (IDH) is a critical …
The prognostic power of [11C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification
Purpose IDH-wildtype (IDH-wt) diffuse gliomas with histological features of lower-grade
gliomas (LGGs) are rare and heterogeneous primary brain tumours.[11C] Methionine (MET) …
gliomas (LGGs) are rare and heterogeneous primary brain tumours.[11C] Methionine (MET) …
Diagnostic performance of [11C] methionine positron emission tomography in newly diagnosed and untreated glioma based on the revised World Health organization …
K Nakajo, T Uda, T Kawashima, Y Terakawa… - World neurosurgery, 2021 - Elsevier
Background The relationship between uptake of amino acid tracer with positron emission
tomography (PET) and glioma subtypes/gene status is still unclear. Objective To assess the …
tomography (PET) and glioma subtypes/gene status is still unclear. Objective To assess the …
[HTML][HTML] A Nomogram Modeling 11C-MET PET/CT and Clinical Features in Glioma Helps Predict IDH Mutation
W Zhou, Z Zhou, J Wen, F Xie, Y Zhu, Z Zhang… - Frontiers in …, 2020 - frontiersin.org
Purpose: We developed a 11C-Methionine positron emission tomography/computed
tomography (11C-MET PET/CT)-based nomogram model that uses easy-accessible imaging …
tomography (11C-MET PET/CT)-based nomogram model that uses easy-accessible imaging …
Recent update on PET/CT Radiotracers for Imaging Cerebral Glioma
D Kim, SH Lee, HS Hwang, SJ Kim, M Yun - Nuclear Medicine and …, 2024 - Springer
Positron emission tomography/computed tomography (PET/CT) has dramatically altered the
landscape of noninvasive glioma evaluation, offering complementary insights to those …
landscape of noninvasive glioma evaluation, offering complementary insights to those …